Clinical Trial Update: Tideglusib: Expanded Access Use in Congenital Myotonic Dystrophy

View source ↗

Summary

This clinical trial update reports expanded access use of Tideglusib for congenital myotonic dystrophy, sponsored by AMO Pharma Limited, and currently available…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Myotonic Dystrophy

Drugs mentioned

• Tideglusib (tideglusib)

Snippet

Sponsor: AMO Pharma Limited | Conditions: Congenital Myotonic Dystrophy | Status: AVAILABLE